One group identified that miR-181b was increased in retinoblastoma cells and enhanced angiogenesis through targeting programmed cell death-10 (PDCD10) and GATA binding protein 6 (GATA6) [68]. This evidence concerns the gene GATA6 and retinoblastoma.